Yahoo
HKSE - Delayed Quote HKD

Lepu Biopharma Co., Ltd. (2157.HK)

3.155 +0.090 (+2.94%)
At close: October 30 at 4:08:06 PM GMT+8
View in AlphaSpace Currency in CNY All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
991,341
934,869
367,794
225,352
15,572
Cost of Revenue
109,225
89,591
74,824
28,277
2,005
Gross Profit
882,116
845,278
292,970
197,075
13,567
Operating Expense
792,697
750,344
667,862
581,404
655,743
Operating Income
89,419
94,934
-374,892
-384,329
-642,176
Net Non Operating Interest Income Expense
-27,081
-24,032
-18,318
-7,968
-474
Pretax Income
256,112
260,636
-424,193
-30,301
-699,441
Tax Provision
1,680
1,750
0
0
0
Net Income Common Stockholders
247,012
261,364
-411,376
-22,096
-689,052
Diluted NI Available to Com Stockholders
247,012
261,364
-411,376
-22,096
-689,052
Basic EPS
0.15
0.15
-0.24
-0.01
-0.42
Diluted EPS
0.15
0.15
-0.24
-0.01
-0.42
Basic Average Shares
1,801,997.500
1,755,085
1,690,482
1,659,445
1,640,825
Diluted Average Shares
1,801,997.500
1,755,085
1,690,482
1,659,445
1,640,825
Total Operating Income as Reported
283,532
285,130
-390,765
4,796
-704,482
Total Expenses
901,922
839,935
742,686
609,681
657,748
Net Income from Continuing & Discontinued Operation
247,012
261,364
-411,376
-22,096
-689,052
Normalized Income
-40,553.223
-27,041.456
-411,369
-242,486
-689,836
Interest Income
3,842
5,277
4,667
8,049
8,173
Interest Expense
30,109
28,161
21,650
14,677
7,467
Net Interest Income
-27,081
-24,032
-18,318
-7,968
-474
EBIT
286,221
288,797
-402,543
-15,624
-691,974
EBITDA
286,221
382,523
-302,364
86,948
-596,528
Reconciled Cost of Revenue
109,225
89,591
74,824
28,277
2,005
Reconciled Depreciation
--
93,726
100,179
102,572
95,446
Net Income from Continuing Operation Net Minority Interest
247,012
261,364
-411,376
-22,096
-689,052
Total Unusual Items Excluding Goodwill
289,464
290,355
-7
220,390
784
Total Unusual Items
289,464
290,355
-7
220,390
784
Normalized EBITDA
-3,243
92,168
-302,357
-133,442
-597,312
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
1,898.777
1,949.544
0
0
0
12/31/2022 - 2/23/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: